Clinical Trial Update: Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating whether the time of day for immunotherapy infusion influences outcomes in neoadjuvant immunochemotherapy for thoracic esophageal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Tang-Du Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING